{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:39:04Z","timestamp":1773797944839,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-026-13642-2","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:35:37Z","timestamp":1769740537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Environmental risk factors and conversion to multiple sclerosis in subjects with radiologically isolated syndrome: a case\u2013control study"],"prefix":"10.1007","volume":"273","author":[{"given":"Chiara","family":"Zanetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Laserra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Giliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Sorosina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaalindi","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Viti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Assunta","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"9","key":"13642_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"DT Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS et al (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72(9):800\u2013805","journal-title":"Neurology"},{"issue":"Pt 11","key":"13642_CR2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059\u20132069","journal-title":"Brain"},{"issue":"2","key":"13642_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1352458517717808","volume":"24","author":"N De Stefano","year":"2018","unstructured":"De Stefano N, Giorgio A, Tintore M, Pia Amato M, Kappos L, Palace J et al (2018) Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler 24(2):214\u2013221","journal-title":"Mult Scler"},{"key":"13642_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.787160","volume":"13","author":"MP Amato","year":"2022","unstructured":"Amato MP, De Stefano N, Inglese M, Morena E, Ristori G, Salvetti M et al (2022) Secondary prevention in radiologically isolated syndromes and prodromal stages of multiple sclerosis. Front Neurol 13:787160","journal-title":"Front Neurol"},{"issue":"9","key":"13642_CR5","first-page":"1542","volume":"41","author":"M Hosseiny","year":"2020","unstructured":"Hosseiny M, Newsome SD, Yousem DM (2020) Radiologically isolated syndrome: a review for neuroradiologists. AJNR Am J Neuroradiol 41(9):1542\u20131549","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"13642_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3174\/ajnr.A4660","volume":"37","author":"Y Forslin","year":"2016","unstructured":"Forslin Y, Granberg T, Jumah AA, Shams S, Aspelin P, Kristoffersen-Wiberg M et al (2016) Incidence of radiologically isolated syndrome: a population-based study. AJNR Am J Neuroradiol 37(6):1017\u20131022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"13642_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1352458512451943","volume":"19","author":"T Granberg","year":"2013","unstructured":"Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S (2013) Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler 19(3):271\u2013280","journal-title":"Mult Scler"},{"issue":"3","key":"13642_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090509","volume":"9","author":"DT Okuda","year":"2014","unstructured":"Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M et al (2014) Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE 9(3):e90509","journal-title":"PLoS ONE"},{"issue":"7","key":"13642_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/archneurol.2009.119","volume":"66","author":"C Lebrun","year":"2009","unstructured":"Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J et al (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 66(7):841\u2013846","journal-title":"Arch Neurol"},{"issue":"8","key":"13642_CR10","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","volume":"146","author":"C Lebrun-Frenay","year":"2023","unstructured":"Lebrun-Frenay C, Okuda DT, Siva A, Landes-Chateau C, Azevedo CJ, Mondot L et al (2023) The radiologically isolated syndrome: revised diagnostic criteria. Brain 146(8):3431\u20133443","journal-title":"Brain"},{"issue":"2","key":"13642_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","volume":"88","author":"C Lebrun-Frenay","year":"2020","unstructured":"Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT (2020) Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol 88(2):407\u2013417","journal-title":"Ann Neurol"},{"issue":"3","key":"13642_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","volume":"93","author":"DT Okuda","year":"2023","unstructured":"Okuda DT, Kantarci O, Lebrun-Frenay C, Sormani MP, Azevedo CJ, Bovis F et al (2023) Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol 93(3):604\u2013614","journal-title":"Ann Neurol"},{"issue":"10","key":"13642_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2023.2815","volume":"80","author":"C Lebrun-Frenay","year":"2023","unstructured":"Lebrun-Frenay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F et al (2023) Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol 80(10):1080\u20131088","journal-title":"JAMA Neurol"},{"issue":"5","key":"13642_CR14","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1007\/s00415-024-12294-4","volume":"271","author":"P Preziosa","year":"2024","unstructured":"Preziosa P, Rocca MA, Filippi M (2024) Radiologically isolated syndromes: to treat or not to treat? J Neurol 271(5):2370\u20132378","journal-title":"J Neurol"},{"issue":"1","key":"13642_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3174\/ajnr.A3653","volume":"35","author":"T Gabelic","year":"2014","unstructured":"Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R et al (2014) Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis. AJNR Am J Neuroradiol 35(1):106\u2013112","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"13642_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jamaneurol.2025.1481","volume":"82","author":"N Fissolo","year":"2025","unstructured":"Fissolo N, Schaedelin S, Villar LM, Lunemann JD, Correale J, Rejdak K et al (2025) Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome. JAMA Neurol 82(7):722\u2013733","journal-title":"JAMA Neurol"},{"issue":"2","key":"13642_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"7","key":"13642_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/jnnp-2024-335547","volume":"96","author":"A Giordano","year":"2025","unstructured":"Giordano A, Giliberti A, Clarelli F, Misra K, Mascia E, Sorosina M et al (2025) Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis. J Neurol Neurosurg Psychiatry 96(7):686\u2013689","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13642_CR19","unstructured":"https:\/\/www.epicentro.iss.it\/passi\/indicatori\/alcol) sabtCfDCaP."},{"key":"13642_CR20","unstructured":"World Health Organization: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index."},{"issue":"10","key":"13642_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28271","volume":"4","author":"C Lebrun-Frenay","year":"2021","unstructured":"Lebrun-Frenay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E et al (2021) Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome. JAMA Netw Open 4(10):e2128271","journal-title":"JAMA Netw Open"},{"key":"13642_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106389","volume":"97","author":"F Condeza","year":"2025","unstructured":"Condeza F, Munoz A, Pelayo C, Garcia L, Del-Canto A, Orellana M et al (2025) Radiologically isolated syndrome: a 6-year follow-up study in Chile. Mult Scler Relat Disord 97:106389","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"13642_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/1352458512436596","volume":"18","author":"AK Hedstrom","year":"2012","unstructured":"Hedstrom AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18(9):1334\u20131336","journal-title":"Mult Scler"},{"issue":"2","key":"13642_CR24","first-page":"181","volume":"87","author":"N Kappus","year":"2016","unstructured":"Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E et al (2016) Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 87(2):181\u2013187","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"13642_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000442203","volume":"46","author":"P Tettey","year":"2016","unstructured":"Tettey P, Siejka D, Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL et al (2016) Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis. Neuroepidemiology 46(2):106\u2013113","journal-title":"Neuroepidemiology"},{"issue":"2","key":"13642_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/acn3.51291","volume":"8","author":"M Marrodan","year":"2021","unstructured":"Marrodan M, Farez MF, Balbuena Aguirre ME, Correale J (2021) Obesity and the risk of multiple sclerosis. The role of leptin. Ann Clin Transl Neurol 8(2):406\u2013424","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13642_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10096-019-03746-1","volume":"39","author":"H EbrahimzadehLeylabadlo","year":"2020","unstructured":"EbrahimzadehLeylabadlo H, Ghotaslou R, SamadiKafil H, Feizabadi MM, Moaddab SY, Farajnia S et al (2020) Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. Eur J Clin Microbiol Infect Dis 39(4):613\u2013627","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13642_CR28","doi-asserted-by":"publisher","first-page":"28484","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM et al (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6:28484","journal-title":"Sci Rep"},{"key":"13642_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R et al (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015","journal-title":"Nat Commun"},{"issue":"13","key":"13642_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131760","volume":"12","author":"A Dunalska","year":"2023","unstructured":"Dunalska A, Saramak K, Szejko N (2023) The role of gut microbiome in the pathogenesis of multiple sclerosis and related disorders. Cells\u00a012(13):1760","journal-title":"Cells"},{"issue":"5","key":"13642_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/elsc.202300070","volume":"24","author":"S Zoghi","year":"2024","unstructured":"Zoghi S, Sadeghpour Heravi F, Nikniaz Z, Shirmohamadi M, Moaddab SY, Ebrahimzadeh Leylabadlo H (2024) Gut microbiota and childhood malnutrition: understanding the link and exploring therapeutic interventions. Eng Life Sci 24(5):2300070","journal-title":"Eng Life Sci"},{"issue":"1","key":"13642_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3339-y","volume":"20","author":"M Vray","year":"2019","unstructured":"Vray M, Hedible BG, Adam P, Tondeur L, Manirazika A, Randremanana R et al (2019) Correction to: A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project). Trials 20(1):211","journal-title":"Trials"},{"issue":"9","key":"13642_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1177\/1352458511435931","volume":"18","author":"C Lebrun","year":"2012","unstructured":"Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT et al (2012) Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler 18(9):1297\u20131302","journal-title":"Mult Scler"},{"issue":"3","key":"13642_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266203","volume":"17","author":"AP Mikkelsen","year":"2022","unstructured":"Mikkelsen AP, Egerup P, Kolte AM, Westergaard D, Nielsen HS, Lidegaard O (2022) Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: a nationwide cohort study. PLoS ONE 17(3):e0266203","journal-title":"PLoS ONE"},{"key":"13642_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.placenta.2023.08.065","volume":"142","author":"C Tang","year":"2023","unstructured":"Tang C, Hu W (2023) The role of Th17 and Treg cells in normal pregnancy and unexplained recurrent spontaneous abortion (URSA): New insights into immune mechanisms. Placenta 142:18\u201326","journal-title":"Placenta"},{"issue":"2","key":"13642_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.fertnstert.2022.10.027","volume":"119","author":"TI Kopp","year":"2023","unstructured":"Kopp TI, Pinborg A, Glazer CH, Magyari M (2023) Assisted reproductive technology treatment and risk of multiple sclerosis - a Danish cohort study. Fertil Steril 119(2):291\u2013299","journal-title":"Fertil Steril"},{"issue":"11","key":"13642_CR37","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1177\/1352458519865118","volume":"26","author":"R Bove","year":"2020","unstructured":"Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K et al (2020) Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Mult Scler 26(11):1410\u20131419","journal-title":"Mult Scler"},{"issue":"6","key":"13642_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","volume":"31","author":"M Toftager","year":"2016","unstructured":"Toftager M, Bogstad J, Bryndorf T, Lossl K, Roskaer J, Holland T et al (2016) Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles. Hum Reprod 31(6):1253\u20131264","journal-title":"Hum Reprod"},{"issue":"10","key":"13642_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Frenay C, Oh J, Arrambide G, Moccia M, Pia Amato M et al (2025) Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 24(10):850\u2013865","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13642-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13642-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:04:15Z","timestamp":1773785055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13642-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13642"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13642-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CZ received compensation for speaking activities, and\/or consulting services, from Alexion, Amgen, Astrazeneca, Biogen, Bristol Myers Squibb, Janssen, Merck, Novartis, Roche, Sandoz, Sanofi; AGio received consulting fees and travel grant from Novartis; FL has nothing to disclose; AGil has nothing to disclose; MS has nothing to disclose; EM has nothing to disclose; KM has nothing to disclose; VV has nothing to disclose; FE received consulting fees from Merck Serono and Genzyme; MAR received consulting fees from Biogen, Bristol Myers Squibb, Roche, and speaker honoraria from Alexion, Biogen, Bristol Myers Squibb, Celgene, Horizon Therapeutics Italy, Merck Serono SpA, Mitsubishi-Tanabe Pharma, Neuraxpharm, Novartis, Roche, Sandoz, and Sanofi, she receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla, she is Associate Editor for\n                      Multiple Sclerosis and Related Disorders\n                      ; and Associate Co-Editor for Europe and Africa for\n                      Multiple Sclerosis Journal\n                      . MF is Editor-in-Chief of the\n                      Journal of Neurology\n                      , Associate Editor of\n                      Human Brain Mapping\n                      ,\n                      Neurological Sciences,\n                      and\n                      Radiology\n                      , received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi, speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA, participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda, scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme, he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Approval was received from the ethical standards committee on human experimentation of IRCCS San Raffaele Hospital (Protocol N\u00b0 REGISTRO SM001 e REGISTRO SM002). Written informed consent was obtained from all patients before study participation in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"106"}}